CLINICAL_TRIALS
trial_result
· 2022-07-26
Clinical Trial Update: Vinorelbine for Recurrent ACLC [Phase 2]
Summary
Phase 2 clinical trial of vinorelbine for recurrent anaplastic large cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Cancer Group, China | Conditions: Anaplastic Large Cell Lymphoma, Vinorelbine | Phase 2 | Status: COMPLETED